Modern Diagnostic & Research Centre Ltd

Modern Diagnostic & Research Centre Ltd. announced its audited financial results for the year ended March 31, 2026. Key highlights include revenue from operations of ₹8311.06 Lacs and profit after tax of ₹525.33 Lacs. The board meeting, held on May 29, 2026, approved the results and took on record the Independent Auditors’ Report. The meeting commenced at 01:19 P.M. and concluded at 02:23 P.M.

Modern Diagnostic & Research Centre Ltd. announced the approval of its audited financial results for the year ended March 31, 2026, during a board meeting held on May 29, 2026. The results include a revenue from operations (net) of ₹8311.06 Lacs and a profit after tax of ₹525.33 Lacs. The board also took on record the Independent Auditors’ Report and a declaration for an unmodified opinion on the audit report.

Modern Diagnostic & Research Centre Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the Quarterly/Annual Financial Statements/Results for the quarter/year ended March 31, 2026. The board will also review the Auditors’ Report submitted by the Statutory Auditors on the Financial Statements/Results for the financial year ended March 31, 2026. The trading window for dealing in the company’s securities remains closed from April 1, 2026, until 48 hours after the declaration of the said Financial Statements/Results.

Modern Diagnostic & Research Centre Ltd. has filed a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, for the year ended March 31, 2026. The filing confirms that promoters and the promoter group hold 72.85% of the company's shares (1,09,99,978 Equity shares) and have not encumbered any of these shares during the financial year.

CARE Ratings, the monitoring agency, has issued a report on the utilization of proceeds from Modern Diagnostic & Research Centre Ltd's IPO for the year ended March 31, 2026. The report, submitted in compliance with SEBI regulations, indicates that the IPO proceeds of ₹36.89 crore were utilized as per the offer document, although there was a delay in utilization. The report declares no deviations from the stated objectives and confirms no conflicts of interest.

Modern Diagnostic & Research Centre Ltd has announced a Board of Directors meeting scheduled for May 13, 2026, to consider and approve the extension of time for utilization of net issue proceeds and project completion, as well as the utilization of funds under General Corporate Purpose for working capital requirements.

Modern Diagnostic & Research Centre Ltd has announced the closure of its trading window in accordance with the company's Code of Conduct and SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure will commence on April 1, 2026, and will remain in effect until 48 hours after the audited financial results for the quarter and year ending on March 31, 2026, are submitted to the Stock Exchange. The date of the Board Meeting to consider these results will be announced separately.

Modern Diagnostic & Research Centre Ltd. has announced a board meeting scheduled for 09/03/2026 to consider and approve various changes and authorizations. These include changing equipment specifications from SPECT to SPECT-CT at Sector 40, Gurugram, changing vendors for building, electrical and air-conditioning works for Diagnostic Centre and certain laboratories outside Delhi, changing the location for opening a laboratory within Delhi, opening a bank account and transferring a loan to Axis Bank, Gurugram, and authorizing the execution of legal, tender, lease/rent, and other miscellaneous documents. The company will also consider entering into any contract or making any sale/purchase on behalf of the company.